Ignite Creation Date:
2024-05-06 @ 3:27 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02291237
Status:
TERMINATED
Last Update Posted:
2018-09-24
First Post:
2014-11-11
Brief Title:
Effect of Eleclazine GS-6615 on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Sponsor:
Gilead Sciences
Organization:
Gilead Sciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hypertrophic Cardiomyopathy |
Keywords:
| Name | View |
|---|---|
| late INA | View |
| hypertrophic cardiomyopathy | View |
| hcm | View |
| hocm | View |
| hypertrophic myocardiopathy | View |
| hypertrophic obstructive cardiomyopathies | View |
| cardiomyopathy | View |
| hypertrophic | View |
| familial hypertrophic cardiomyopathy | View |
| genetic heart disease | View |
| echocardiography | View |
| cardiopulmonary exercise testing | View |
| exercise Capacity | View |
| heart failure | View |
| angina | View |
| dyspnea | View |
| diastolic dysfunction | View |
| microvascular ischemia | View |
| late sodium current inhibitor | View |
| GS-6615 | View |